Patent Application
20060029995
The present invention relates generally to biotechnology, and more particularly to a novel class of metacaspases. Even more particularly, the present invention relates to the use of metacaspases, preferably plant metacaspases to process a protein at a cleavage site comprising an arginine or a lysine at the P1 position, and to the use of such metacaspases to modulate cell death.
Cell death is a certainty for every living bacterial, unicellular, or multicellular organism. In what is generally called programmed cell death (“PCD”), cell death is triggered by extracellular or intracellular signals, and it is associated with development and environmental stress. In animals, cell death occurs mainly in development, tissue remodeling, and immune regulation, but it is also involved in many pathologies (Ellis et al., 1991; Williams, 1994). Based on primarily morphological features, animal cell death is usually referred to as apoptosis or necrosis. Apoptosis is characterized by membrane blebbing, cytosolic condensation, cell shrinkage, nuclear condensation, breakdown of nuclear DNA (DNA laddering), and finally the formation of apoptotic bodies, which can easily be taken up by other cells (Fiers et al., 1999). Necrosis, as defined on a microscopic level, denotes cell death where cells swell, round up, and then suddenly collapse, spilling their contents in the medium. However, in animals other forms of cell death exist, like autophagic and autolytic death, and it is now gradually accepted that all intermediate varieties of cell death can occur (Lockshin and Zakeri, 2002).
Also, in plants, cell death is a prerequisite process in development, morphogenesis, maintenance and reproduction (Greenberg, 1996; Pennell and Lamb, 1997; Buckner et al., 2000). During reproductive development, cell death is involved in a plethora of processes like pollen grain production, female gametophyte formation, pollination, and embryogenesis (Wu and Cheun, 2000). In cereals, formation of the starchy endosperm requires apoptosis-like cell death, while the cells of the aleurone layer die a few days after germination through a rather autolytic process (Young and Gallie, 2000; Fath et al., 2000). During growth of a plant, formation of tracheary elements from procambium, as experimentally represented by differentiating Zinnia cells, relies on a type of cell death that is characterized by vacuolar collapse, a process which is probably orchestrated by the mitochondria (Yu et al., 2002; Fukuda, 2000). Especially important for worldwide agriculture is cell death as part of the hypersensitive response (HR) of plants to pathogens (for reviews, see ref. Greenber, 1997; Heath, 2000; Morel and Dangl, 1997). The HR is a rapid process, mainly characterized by the appearance of small lesions at the site of pathogen infection, a plant-directed strategy which is that of the “scorched earth”. Thus, the death of plant cells at the site of infection is deleterious for pathogens, at least for so-called obligate biotrophic ones.
In plants, PCD or “active cell death” are terms usually applied to denote apoptosis-like cell death, showing features like chromatin aggregation, cell shrinkage, cytoplasmic and nuclear condensation and DNA fragmentation (Buckner et al., 2000; Jabs, 1999; O'Brien et al., 1998). Apoptotic characteristics have been observed during HR and following abiotic stress, such as ozone, UV irradiation, chilling and salt stress (Pennell and Lamb, 1997; Danon and Gallois, 1998; Katsuhara, 1997; Kratsch and Wise, 2000; Pellinen et al., 1999). Necrosis or “passive cell death” is used to describe cell death that results from severe trauma during extreme stress situations and occurs immediately and independently of any cellular activity (O'Brien et al., 1998).
On a biochemical level, apoptosis in animals is characterized, and commonly also defined, by the activation of a distinct family of cysteine-dependent aspartate-specific proteases or caspases (Earnshaw et al., 1999). Mature active caspases are derived from their zymogen by proteolysis at specific aspartate residues, removing an N-terminal prodomain and separating the large (p20) and small (p10) subunits, two of each forms a fully active caspase enzyme.
The unprocessed forms of most caspases already possess low intrinsic protease activity. Thus, during cell death signaling, the most upstream caspases, called initiator caspases, associate through their large prodomain with adaptor proteins and are forced to auto-process by what is known as induced proximity. The resulting fully active caspases are then able to proteolytically activate downstream executioner caspases. These are able to cut a variety of cellular substrates, resulting in a plethora of structural and metabolic alterations, ultimately leading to an organized death of the cell. (Earnshaw et al., 1999; Utz and Anderson, 2000; Cohen, 1997).
Using synthetic oligopeptide caspase substrates and inhibitors, caspase-like activity could already be demonstrated in various plant cell death models. Co-infiltration in tobacco of caspase-inhibitors with an incompatible Pseudomonas syringae pathovar prevented HR (del Pozo and Lamb, 1998). Also, chemical-induced cell death in tomato cells could be blocked by addition of different caspase inhibitors (De Jong et al., 2000). Tobacco plants infected by the tobacco mosaic virus show protease activity as measured by Ac-YVAD-AMC, a synthetic substrate for caspase-1 (del Pozo and Lamb, 1998). When soybean cells are subjected to oxidative stress, cysteine proteases are activated, and inhibition of some of these by cystatin almost completely blocked cell death (Solomon et al., 1999). Korthout and co-workers showed that embryonic barley cells contain caspase 3-like activity, as measured with the specific substrate acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (Ac-DEVD-AMC) (Korthout et al., 2000). Recently, Uren et al. (2000) reported the existence of two families of distant caspase homologues in plants, fungi, protozoa and animals. Paracaspases are, like caspases, restricted to the animal kingdom, while “metacaspases” can be found in plants, fungi, and protozoa. However, the existence of these metacaspases was only derived from in silico data, and the activity of the metacaspases has not been demonstrated. Moreover, it was clearly stated that it remained to be seen whether the stress-induced caspase activity in plants is exerted by the metacaspases, or by other unknown members of the caspase-like superfamily.
Surprisingly, we have found a new member of the metacaspase family and have determined its activity. In contrast to the known caspases, that have a D residue at position P1, the novel metacaspase family cuts after arginine and/or lysine, i.e., its recognition site has either an R or a K at position P1. Preferably, the novel metacaspase family cuts after arginine. Even more preferably, the novel metacaspase family cuts after arginine and lysine.
A first aspect of the invention is the use of a metacaspase to process a protein at a cleavage site comprising arginine and/or lysine at position P1. Although there are proteases known, such as clostripain and gingipain that cut at a cleavage site with an R or K at position P1, those proteases are only distantly related and show no significant overall homology with the metacaspases described here. One preferred embodiment is a metacaspase according to the invention that is active at acidic pH. Preferably, the metacaspase shows it maximal activity at acidic pH, preferably in a ph range of 5-6, even more preferably in a pH range of 5.2-5.5.
Another preferred embodiment is a metacaspase according to the invention that is active at alkaline pH. Preferably, the metacaspase shows it maximal activity at alkaline pH, preferably in a pH range of 7-8, even more preferably in a pH range of 7.5-8.0.
Preferably the metacaspase used according to the invention is a plant metacaspase. Even more preferably, the metacaspase is selected from the group consisting of polypeptides comprising, preferably consists essentially of, more preferably consisting of SEQ ID NO:1 SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:40, SEQ ID NO:41 and SEQ ID NO:42 or a functional fragment thereof. In one preferred embodiment, the metacaspase used according to the invention comprises SEQ ID NO:1, or a functional fragment thereof. Preferably, the metacaspase used according to the invention consists essentially of SEQ ID NO:1, or a functional fragment thereof. Most preferably, the metacaspase used according to the invention consists of SEQ ID NO:1, or a functional fragment thereof. Typical functional fragments are the so-called p10 and p20-like fragments. Preferably, the functional fragment consists essentially, even more preferably consisting of SEQ ID NO:2.
In another preferred embodiment, the metacaspase used according to the invention comprises SEQ ID NO:42, or a functional fragment thereof. Preferably, the metacaspase used according to the invention consists essentially of SEQ ID NO:42, or a functional fragment thereof. Most preferably, the metacaspase used according to the invention consists of SEQ ID NO:42, or a functional fragment thereof. Preferably, the functional fragment of SEQ ID NO:42 is a fragment where the prodomain (amino acid 1-91) is deleted.
Another aspect of the invention is the use of a metacaspase, which cleaves at a cleavage site comprising arginine and/or lysine at position P1, to modulate cell growth, preferably to modulate cell death, even more preferably to modulate programmed cell death. Preferably, the metacaspase cuts after arginine. Even more preferably, the metacaspase cuts after arginine and lysine. Preferably, the modulation of cell death is obtained in plant cells. Preferably the metacaspase used according to the invention is a plant metacaspase. Even more preferably, the metacaspase is selected from the group consisting of polypeptides comprising, preferably consists essentially of, more preferably consisting of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:40, SEQ ID NO:41 and SEQ ID NO:42 or a functional fragment thereof.
In one preferred embodiment, the metacaspase used according to the invention comprises SEQ ID NO:1, or a functional fragment thereof. Preferably, the metacaspase used according to the invention consists essentially of SEQ ID NO:1, or a functional fragment thereof. Most preferably, the metacaspase used according to the invention consists of SEQ ID NO:1, or a functional fragment thereof. Typical functional fragments of SEQ ID NO:1 are the so-called p10 and p20-like fragments. Preferably, the functional fragment consists essentially, even more preferably consisting of SEQ ID NO:2. In another preferred embodiment, the metacaspase used according to the invention comprises SEQ ID NO:42, or a functional fragment thereof. Preferably, the metacaspase used according to the invention consists essentially of SEQ ID NO:42, or a functional fragment thereof. Most preferably, the metacaspase used according to the invention consists of SEQ ID NO:42, or a functional fragment thereof. Preferably, the functional fragment of SEQ ID NO:42 is a fragment where the prodomain is deleted.
The modulation can be an increase as well as a decrease of cell death. An increase of cell death can be obtained by overexpression of the metacaspase according to the invention; the effect of the metacaspase may be either direct, by degradation of essential proteins, or indirect, by activation of other proteases or lytic enzymes. An increase in cell death may be interesting, as a non-limiting example, incase of pathogen response, wherein the gene encoding the metacaspase is operably linked to a pathogen inducible promoter. Pathogen inducible promoters are known to the person skilled in the art, and have been disclosed, among other places, in PCT International Patent Publications WO9950428, WO0001830, and WO0060086. Alternatively, cell death may be wished to obtain tissue abortion, such as in the case of male sterility. In this case, the gene encoding the metacaspase can operably linked to a tissue specific promoter. Tissue specific promoters are also known to the person skilled in the art.
A decrease of cell death can be obtained by downregulation of the expression of the metacaspase, of by inhibition of its activity. Inhibition of the activity can be realized in several ways. As non-limiting example, the self-processing can be blocked, e.g., by mutagenesis of the cleavage site. Alternatively, a specific inhibitor may be used. As a non-limiting example, a specific inhibitor may be an antibody that binds to the active site of the metacaspase, or an antibody that binds to the cleavage site of the substrate, or a peptide or peptidomimetic comprising the cleavage site.
Therefore, still another aspect of the invention is the use of an inhibitor of a metacaspase, which cleaves at a cleavage site comprising arginine or lysine at position P1, to inhibit cell death, preferably programmed cell death. Preferably, the metacaspase cleaves after arginine. Even more preferably, the metacaspase cleaves after arginine and lysine. Preferably, the inhibition of cell death is obtained in plant cells. Preferably the metacaspase inhibited according to the invention is a plant metacaspase. Even more preferably, the metacaspase is selected from the group consisting of polypeptides comprising, preferably consists essentially of, more preferably consisting of SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, SEQ ID NO:7, SEQ ID NO:40, SEQ ID NO:41 and SEQ ID NO:42 or a functional fragment thereof. In one preferred embodiment, the metacaspase inhibited according to the invention comprises SEQ ID NO:1, or a functional fragment thereof. Even more preferably, the metacaspase inhibited according to the invention consists essentially of SEQ ID NO:1, or a functional fragment thereof. Most preferably, the metacaspase inhibited according to the invention consists of SEQ ID NO:1, or a functional fragment thereof. Typical functional fragments of SEQ ID NO:1 are the so-called p1 and p20-like fragments. Preferably, the functional fragment consists essentially, even more preferably consists of SEQ ID NO:2. In another preferred embodiment, the metacaspase inhibited according to the invention comprises SEQ ID NO:42, or a functional fragment thereof. Preferably, the metacaspase inhibited according to the invention consists essentially of SEQ ID NO:42, or a functional fragment thereof. Most preferably, the metacaspase inhibited according to the invention consists of SEQ ID NO:42, or a functional fragment thereof. Preferably, the functional fragment of SEQ ID NO:42 is a fragment where the prodomain is deleted.
Inhibition of cell death does not imply that no cell death at all is occurring, but it means that a significant decrease if obtained in the cells, treated with the inhibitor when compared to the non-treated cells.
Definitions
“Metacaspase”, as used herein, is a polypeptide with proteolytic activity, comprising in its non-processed form the sequences H Y/F SGHG (SEQ ID NO:8; amino acid residues 82-87 of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:7; amino acid residues 1-6 of SEQ ID NO:10; amino acid residues 196-210 of SEQ ID NO:41; and amino acid residues 170-175 of SEQ ID NO:42) and D A/S C H/N SG (SEQ ID NO:9; amino acid residues 163-168 of SEQ ID NO:1; amino acid residues 137-142 of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:7; amino acid residues 1-6 of SEQ ID NO:11; amino acid residues 219-223 of SEQ ID NO:40; and amino acid residues 228-233 of SEQ ID NO:42). Preferably, the polypeptide comprises, in its non-processed form, the sequences HYSGHGT (SEQ ID NO:10; and amino acid residues 82-87 of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID NO:6, and SEQ ID NO:7) and/or DSCHSGGLID (SEQ ID NO:11; and amino acid residues 163-172 of SEQ ID NO:1).
Functional fragment as used herein means that the fragment is essential for metacaspase activity. However, it does not imply that the fragment on its own is sufficient for activity. Typical functional fragments for the type II metacaspases are the so-called p10 and p20-like fragments. Typical functional fragments for the type I metacaspases are fragments where the so-called prodomain has been deleted.
The metacaspase activity as defined herein means the proteolytic activity, by which a protein is processed at a cleavage site comprising an arginine or lysine residue at position P1. Preferably, the metacaspase cleaves after arginine. Even more preferably, the metacaspase cleaves after arginine and lysine.
Position P1 is the C-terminal residue of the fragment upstream of the cleavage site (the amino-terminal fragment).
Derived from a plant as used here means that the gene, encoding the metacaspase, was originally isolated from a plant. It does not imply that the metacaspase is produced in, or isolated from a plant. Indeed, the metacaspase may be produced in another host organism, such as a bacterium, wherein it is either isolated after production, or exerts its activity in vivo in the host.
Operably linked refers to a juxtaposition wherein the components so described are in a relationship permitting them to function in their intended manner. A promoter sequence “operably linked” to a coding sequence is ligated in such a way that expression of the coding sequence is achieved under conditions compatible with the promoter sequence.
An acidic pH as used here means a pH below pH 7, preferably below pH 6.5, even more preferably below ph 6. The most preferred range is between pH 5 and 6, even more preferred between 5.2 and 5.5. An alkaline pH as used here means a pH above pH 7, preferably above pH 7.5. The most preferred range is between pH 7.5 and 8.
The invention is further explained with the aid of the following illustrative examples.
Materials and Methods too the Examples
Used Databases for the Detection of the Genes for Arabidopsis Metacaspases
A genome-wide, non-redundant collection of Arabidopsis protein-encoding genes was predicted with Gene-Mark.hmm (Lukashin and Borodovsky, 1998). Based on these predictions, searchable databases of virtual transcripts and corresponding protein sequences were generated.
Cloning of Arabidopsis Metacaspase ORF's
Total RNA was isolated from leaves, inflorescences and roots of young and mature plants. First strand cDNA was synthesized from pooled RNA using Superscript II RNase H—RT (Invitrogen, Gaithersburg, Md., USA) using the manufacturer's instructions, and used as template for PCR reactions using PLATINUM Pfx DNA polymerase (Invitrogen, Gaithersburg, Md., USA) and the following forward and reverse primers:
Atmc1: 5′ATGTACCCGCCACCTCC3′ (SEQ ID NO:12) and 5′CTAGAGAGTGAAAGGCTTTGCATA3′ (SEQ ID NO:13);
PCR products were purified using gel electrophoresis and used as template in a second PCR with attB1 and attB2 primers, to allow subsequent Gateway cloning procedures (Invitrogen). Products were purified on gel and cloned into pDONR201 to generate entry vectors for each metacaspase.
Alignment of Metacaspase Sequences
Sequences were aligned using clustalX (Thompson et al., 1997), and manually edited with BioEdit (Hall, 1999). For shading of the alignment, amino acid groups as described in (Wu and Brutlag, 1995) were used. Besides identical amino acids, those belonging to the following groups were scored as highly homologous: [PAGST], [QNED], [KRH], [VLIM] and [FYW], and are shaded black (all metacaspases) or dark gray (one type of metacaspases only) in the alignment. The following groups were used to determine weakly conserved residues: [PAGSTQNEDHKR] (SEQ ID NO:35) and [CVLIMFYW] (SEQ ID NO:36).
Phylogeny
To determine metacaspase orthologues, a profile constructed with annotated eukaryotic metacaspase protein sequences was used to search the public protein databases (HMMer; Eddy, 1998). Protein sequences of putative metacaspases were aligned to the profile using CLUSTALW (Thompson et al., 1994). Manual editing of the alignment was performed with BioEdit (Hall, 1999), reformatting using For Con (Raes and Van de Peer, 1999). Phylogenetic trees were constructed with the Maximum-Likelihood program TREE-PUZZLE (Schmidt et al. 2002) and the Neighbour-Joining algorithm, implemented in TREECON (Van de Peer and De Wachter, 1994) on the region probably corresponding to the p20 subunit. Distance matrices were calculated based on the Poisson correction.
Bacterial Production and Antibodies
The cDNAs for metacaspases were cloned into the bacterial expression vector pDEST17 (Invitrogen), resulting in N-terminal addition of the amino acid sequence MSYYHHHHHHLESTSLYKKAGST (SEQ ID NO:37), and the plasmids were introduced into E. coli strain BL21(DE3). Bacterial cultures were induced with 1 mM IPTG for 1-3 hours, cells were spun down and lysed under denaturing conditions adapted from Rogl et al. (1998). Briefly, the bacterial cell pellet from a 0.5 l culture was lysed using 5 ml 100 mM Tris.Cl pH 8.0, 20 ml 8.0 M urea, and 2.7 ml 10% sodium N-lauroyl-sarcosinate, completed with 1 mM PMSF and 1 mM oxidized glutathione. After sonication, the volume was brought to 50 ml with buffer 1 (20 mM Tris.Cl pH 8.0, 200 mM NaCl, 10% glycerol, 0.1% sodium N-lauroyl-sarcosinate, 1 mM PMSF and 1 mM oxidized glutathione). The lysate was applied to a 2 ml Ni-NTA column (Qiagen) equilibrated with buffer 1. The column was washed with buffer 2 (buffer 1 with 0.1% Triton-X100 instead of 0.1% sodium N-lauroyl-sarcosinate). After this, the column was washed with buffer 2, supplemented with 10 mM imidazole. Recombinant metacaspases were eluted with 300 mM imidazole in buffer 2 and checked by 12% PAGE.
For rabbit polyclonal antisera, 400 μg of purified recombinant metacaspase per rabbit was used as immunogen (Eurogentec, Herstal, Belgium).
Metacaspase-binding scFv antibodies were selected from a naive human scFv phage display library by panning. Briefly, protein antigens were coated at a concentration of 2.5-100 μg/ml in 2 ml Phosphate Buffered Saline (PBS) in immunotubes for 16-18 hours at 4° C. The tubes were washed 3 times with PBS and blocked with 4 ml 2% Skim Milk in PBS (SM-PBS). 7.5×1012 phages were incubated in the immunotube, in 2 ml 2% SM-PBS for 2 hours at room temperature. The tubes were washed 10 times with 4 ml 0.1% Tween20 in PBS (T-PBS), and 5 times with 4 ml PBS. Bound phages were eluted with 1 ml 100 mM triethylamine for 5 min at room temperature, and neutralized immediately with 0.5 ml 1M Tris-HCl pH 7.4. TG1 cells were infected with the eluted phages, and a new phage stock was prepared for the next panning round. Two to three panning rounds were performed, before individual clones were tested in ELISA. Positive clones were further analyzed by MvaI fingerprinting. ScFv stocks were prepared by scFv production in E. coli HB2151 containing the pHEN2-scFv phagemid. Periplasmic extracts containing the scFv were prepared according to the Expression Module of the RPAS kit (Amersham Pharmacia Biotech).
Agroinfiltration and Expression of Metacaspases in N. benthamiana and Mammalian Cells
The cDNAs for the metacaspases were cloned into the binary vector pB7WG2D (Karimi et al., 2002). This vector carries an expression cassette for CaMV35S-driven constitutive expression of the cloned cDNA, a separate expression cassette for EgfpER under transcriptional control of the rolD promoter, and the selectable marker bar under control of the nos promoter, the whole flanked by nopaline-type T-DNA left and right borders for efficient transfer and genomic insertion of the contained sequence.
Binary vectors were transformed into Agrobacterium tumefasciens strain LBA4404 supplemented with a constitutive virGN54D mutant gene (van der Fits et al, 2000). For infiltration, bacteria were grown until exponential growth phase, washed and diluted to an OD600 of 0.2 in 10 mM MES pH5.5, 10 mM MgSO4, and bacterial suspensions were injected into mature leaves of 5-week-old Nicotiana benthamiana by applying gentle pressure on the abaxial side of the leaves using a 1 ml-syringe. Plants were kept under a 16 h light/8 h dark regime at 22° C. and 70% humidity (Yang et al., 2000).
For mammalian overexpression, cDNAs for metacaspases were cloned into pDEST26 (Invitrogen, Gaithersburg, Md., USA), resulting in an N-terminal HIS6-fusion under transcriptional control of the constitutive CMV promoter. Human embryonic kidney cells 293T were cultured in DMEM supplemented with 2 mM L-glutamine, 10% fetal calf serum, 106 U/i streptomycin, 100 mg/ml penicillin and 0.4 mM sodium pyruvate. 5×105 cells (6 well plate) were seeded and next day transfected using the calcium phosphate method as described previously (Van de Craen et al., 1998).
Immunoblot Analysis
For bacterial expression analysis, induced bacterial cultures harboring the pDEST17 expression plasmid were collected after 1 to 3 hours by centrifugation and resuspended in PBS to an OD600 of 10.5 μl per sample were loaded on gel, and after blotting analyzed with mouse penta-HIS-specific antibodies (Qiagen, Hilden, Germany).
For plant expression analysis, leaves were harvested and snap-frozen in liquid nitrogen. Extracts were prepared by grinding material and extracting with protein extraction buffer (10 mM Tris.Cl pH 7.5, 200 mM NaCl, 5 mM EDTA, 10% glycerol, 0.1% Triton-X100, 1 mM oxidized glutathione, Complete™ protease inhibitor cocktail, Roche Applied Science, Mannheim, Germany). For mammalian expression analysis, cells were scraped in medium from the plate and harvested by centrifugation. The cell pellet was lysed by adding 150 μl lysis buffer (1% NP-40, 200 mM NaCl, 10 mM Tris HCl pH 7.0, 5 mM EDTA, 10% glycerol supplemented freshly with 1 mM PMSF, 0.1 mM aprotinin and 1 mM leupeptin). Typically 10-20 μg total protein were loaded and run on a 12% polyacrylamide gel, blotted, and metacaspases were detected using mouse penta-HIS-specific antibodies (Qiagen, Hilden, Germany), rabbit antiserum ( 1/2000 dilution) or cMyc-tagged monoclonal single-chain antibodies ( 1/2000) together with mouse anti-cMyc (clone 9E10, Sigma). Appropriate HRP-conjugated secondary antibodies were from Amersham Pharmacia Biotech (Roosendaal, The Netherlands). Human PARP-1 was detected with the mouse monoclonal antibody C-2-10 (Biomol Research Laboratories, Inc., PA, USA).
Purification and N-Terminal Peptide Sequencing of Metacaspase Fragments
Automated N-terminal Edman degradation of the immobilized proteins was performed on a 476A pulsed liquid sequenator equipped with an on-line phenylthiohydantoin-derivative analyser (Applied Biosystems, Foster City, Calif.). Prior to Edman degradation the blots were sequentially washed with water and methanol. Mass determination has been performed on a 4700 proteomics analyzer (Applied Biosystems, Foster City, Calif.), using the linear mode. External calibration was done with myoglobin. The p10-like fragment of Atmc9 could be purified via reversed phase HPLC in two steps as follows: Ni-NTA-purified bacterially produced protein was applied on a PLRP-S column (Polymer Labs, 4.6×200 mm, eluent A=0.1% TFA, eluent B=90% isopropanol in 0.07% TFA) to separate the mixture in two fractions, i.e., fraction 1 between ˜80-85% eluent B and fraction 2 between ˜85 and 95% eluent B. The second fraction was then separated using a μRPC column (Amersham Biotech, 4.6×100 mm, eluent A 0.1% TFA, eluent B 90% MeCN in 0.1% TFA). The p10-like fragment was eluted as a single peak at ˜60% eluent B.
Metacaspase Assays, Substrates, and Inhibitors
All tested fluorogenic substrates were from Bachem (Bubendorf, CH) and inhibitors from Sigma-Aldrich (St. Louis, Mo., USA), except for the caspase inhibitors, Z-FA-fink and Z-FK-2,4,6-trimethylbenzoyloxymethyl ketone (Z-FK-tbmk) from Enzyme Systems Products (Livermore, Calif., USA). Assays were performed in 150 μl with 400 ng of purified Atmc9 and 50 μM substrate in an optimized metacaspase 9 assay buffer (50 mM MES pH 5.3, 10% (w/v) sucrose, 0.1% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate [CHAPS], 10 mM DTT). Time-dependent release of free amido-4-methylcoumarin (AMC) was measured on a Cytofluor 4000 fluorescence microplate reader (PerSeptive Biosystems, Farmingham, Md., USA).
GFP Fusions, Generation of Transgenic BY-2 Lines, and Subcellular Localization
The cDNAs for the studied metacaspases lacking the stop codon were cloned into the binary vector pK7FWG2 (Karimi et al., 2002), resulting in the C-terminal fusion of the enhanced green-fluorescent protein (Egfp) cDNA under control of the constitutive cauliflower mosaic virus 35S promotor. Binary vectors were transformed into Agrobacterium tumefaciens strain LBA4404 supplemented with a constitutive virG N54D mutant gene (van der Fits et al., 2000). Suspension-cultured tobacco (Nicotiana tabacum L.) BY-2 cells were grown and transformed as described (Geelen and Inze, 2001). Confocal laser scanning microscopy analysis was performed on a LSM510 microscopy system (Zeiss, Jena, Germany) composed of an Axiovert inverted microscope equipped with an argon ion laser as an excitation source and a 60× water immersion objective. BY-2 cells expressing GFP fusions were excited with a 488-nm laser line. GFP emission was detected with a 505- to 530-nm band-pass filter. The images were captured with the LSM510 image acquisition software (Zeiss).
Using the sequences of eight Arabidopsis metacaspases as reported by Uren et al. (2000), a sequence homology search (blastp, Altschul et al., 1997) was performed against an in-house collection of protein sequences corresponding to predicted Arabidopsis protein-encoding genes (EUGENE, Schiex et al., 2001). This resulted in the detection of one extra putative metacaspase gene (genes named Atmc1 to −9). The alignment of the corresponding protein sequences is shown in
The nine metacaspases genes are localized on chromosomes I, IV and V. Previous genomic analysis revealed that the Arabidopsis genome consists of a large number of duplicated blocks, which might be the results of one or many complete genome duplications (AGI, 2000; Raes et al., 2003; Simillion et al., 2002). Comparison of the genomic organization of all nine Arabidopsis metacaspases and these duplicated segments shows that Atmc8 gene is linked with genes Atmc4 to −7 by an internal duplication event on chromosome I. In addition, genes Atmc4 to −7 are organized in tandem within a region of 10.6 kb on chromosome I. Taking into account the family tree topology (see
Three of the Arabidopsis metacaspases (1 to 3) possess an N-terminal extension as compared to the other six proteins, and were previously termed “type I metacaspases” (
Immediately following the prodomain a conserved region of approximately 160 amino acids can be observed, corresponding to calculated molecular weights of around 17 kDa, which corresponds to the molecular weight of p20 subunits of most mammalian caspases (Earnshaw et al., 1999). Carboxy-terminally, another region of homology exists, 140 residues long, with calculated molecular weights of ˜15 kDa, reminiscent of the p10 of caspases. In between these putative p20 and p10 domains, a region exists that differs considerately between type I and II metacaspases. While type I metacaspases have a putative linker of approximately 20 amino acids, the linker in type II metacaspases is between 90 (for Atmc9) and 150 residues long.
To determine the evolutionary relationship of the Arabidopsis metacaspases with other organisms, phylogenetic trees were constructed. As sequence data for many organisms is not complete, only the p20 region was used for alignment.
We initiated a biochemical analysis by overexpression of HIS-tagged versions of all available Arabidopsis metacaspases in bacteria. In parallel, mutant forms in which the presumed catalytic cysteine (Cys220, Atmc1 numbering) is replaced by an alanine (C/A mutation) were produced.
Overexpression of caspases in mammalian cells often leads to auto-activation of the expressed caspase and subsequent cell death (Earnshaw et al., 1999). Because of the structural homology between metacaspases and caspases, and the above observations that overexpression of metacaspases, at least for type II, results in the generation of p10 and p20 look-alikes, we tested whether plant metacaspases are active in a mammalian context. To that purpose, the N-terminally HIS6-tagged cDNA's for wild-type and C/A mutants of Atmc1 and -9, under transcriptional control of the constitutive CMV promoter, were transfected into a human embryonic kidney cell line, 293T. Cells were followed for morphological changes typical for apoptosis in these cells, being blebbing of the plasma membrane, cytosolic condensation and the fragmentation into apoptotic bodies. However, no clear effect could be detected until up to 72 hours post-transformation. In parallel, expression levels of the metacaspases 48 hours post-transfection were analyzed by Western blotting. Polyclonal anti-Atmc1 antibodies recognized both wild-type and C/A mutant HIS-tagged Atmc1 only as full-length (52 kDa apparent MW), and no processing could be seen (
As cell death was not evident on a morphological basis, we checked whether proteolytic cleavage of poly(ADP ribose) polymerase-1 (PARP-1) could be detected. During mammalian apoptosis, PARP-1 is cleaved by caspases 3 and 7 into fragments of 89 and 14 kDa, and this processing is often used as a hallmark for apoptotic cell death (Kaufmann et al., 1993; Lazebnik et al., 1994; Germain et al., 1999). Using a monoclonal antibody recognizing the amino-terminal part of human PARP-1, full-length PARP-1 could be detected as a band at 115 kDa in all samples. However, when Atmc9 was overexpressed, a fragment of approximately 62 could be detected. This is completely reminiscent of the necrotic cleavage of PARP-1, as reported previously (Gobeil et al., 2001, Casiano et al., 1998). At 48 h post-transfection, this PARP-1 cleavage was hardly detectable in any of the other samples. At 72 h post-transfection, PARP-1 cleavage could also be detected in other samples, albeit to a lesser extent (not shown). Probably, this necrotic processing is the consequence of cell death by nutrient starvation, which is accelerated by active Atmc9. We conclude that, either directly or indirectly, overexpression in human cells of an active form of Atmc9 leads to necrotic processing of PARP-1.
Lysates from 293T cells overexpressing metacaspases were also incubated with different synthetic fluorigenic substrates for caspases, namely acetyl-Asp-Glu-Val-Asp-aminomethylcoumarin (Ac-DEVD-amc), acetyl-Ile-Glu-Thr-Asp-aminomethylcoumarin (Ac-IETD-amc), Acetyl-Leu-Glys-His-Asp-aminomethylcoumarin (Ac-LEHD-amc), acetyl-Trp-Glu-His-Asp-aminomethylcoumarin (Ac-WEHD-amc), Acetyl-Tyr-Val-Ala-Asp-aminomethylcoumarin (Ac-YVAD-amc) and benzyloxycarbonyl-Val-Ala-Asp-aminomethylcoumarin (zVAD-amc). However, no significant increase in activity could be measured with any of these substrates, while lysates from cells overexpressing murine caspase-3 showed clear DEVD-ase activity. Therefore, although Arabidopsis thaliana metacaspase 9 (Atmc9) overexpression results in autoprocessing, this does not lead to classical caspase-like activity.
Next, we introduced the ORFs for Atmc1 and -9, under transcriptional control of the constitutive 35S CaMV promoter, into tobacco leaves by Agrobacterium infiltration. To investigate the role of the presumed catalytic cysteine, Atmc1C/A and -9C/A mutants were also tested.
Plants were visually scored for the appearance of necrotic lesions during the following days. However, no consistent effect of overexpression of metacaspases could be observed. Therefore, expression levels of the different proteins were assessed by Western analysis. Using parallel overexpression of GFP, transformation efficiency was shown to be similar in all setups. Expression of the different Atmc's was analyzed using metacaspase-specific antisera. As shown in
Despite repeated overexpression experiments using different titers of Agrobacterium and plant growth conditions, and the fact that autocatalytic processing was triggered upon metacaspase overexpression, no concomitant cell death could be seen. We therefore conclude that mere over-expression of type II metacaspases may be sufficient for autocatalytic processing, but that this does not result in cell death.
As bacterial overproduction of Atmc9 is sufficient for autoprocessing, we characterized the putative p20 and p10 fragments by N-terminal peptide sequencing and by determination of their molecular mass by mass-spectrometry. When HIS-tag-purified Atmc9 was analyzed on PAGE and silver staining, major fragments with apparent molecular masses of 28, 21 and 16 kDa were visible (not shown). Previous experiments revealed that of these, only the 28 kDa fragment could be detected with anti-HIS6 antibody, and thus could represent the HIS-tagged p20-like subunit. Therefore we reasoned that the band at 21 kDa could represent the mature p20, i.e., after removal of the HIS-tag and a short prodomain. The other fragment, at 16 kDa, could then be the p10-like subunit. The p10-like fragment could be purified sufficiently to directly submit it to Edman degradation sequencing. This resulted in the peptide sequence ALPFKAV, which indicates that the p10 is generated by cleavage after Argl83. As can be seen on the sequence alignment in
As the putative p20 subunit could not be purified, separation by PAGE was necessary first to isolate this fragment. Peptide sequencing revealed that the N-terminus of this fragment was generated by cleavage in the short linker between the HIS6-tag and Atmc9, more precisely after the two lysines in the sequence MSYYHHHHHHLESTSLYKKAGSTM (SEQ ID NO:39), where the last methionine is the start of Atmc9. However, as can be seen on
The autocatalytic cleavage sites of Atmc9 are shown on
Several artificial substrates of Atcm9 were tested and the kcat/Km was determined.
The activity assay buffer used was composed of 50 mM MES pH 5.3, 10% (w/v) sucrose, 0.1% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate [CHAPS], 10 mM DTT.
The concentration of active sites in the preparation of rAtmc9 was determined by active site titration with the irreversible inhibitor Z-FK-2,4,6-trimethylbenzoyloxymethyl ketone (Z-FK-tbmk; Enzyme Systems Products, Livermore, Calif., USA) to be 30 μM.
For determination of kcat/Km, 50 μl of 20 μM of the tested substrates (t-butyloxycarbonyl-Gly-Lys-Arg-7-amido-4-methylcoumarin (Boc-GKR-AMC); t-butyloxycarbonyl-Gly-Arg-Arg-7-amido-4-methylcoumarin (Boc-GRR-AMC); benzyloxycarbonyl-Phe-Arg-AMC (Z-FR-AMC); H-Ala-Phe-Lys-7-amido-4-methylcoumarin (H-AFK-AMC)) was mixed with 50 μl 600 nM rAtmc9 (final concentrations 300 nM rAtmc9 and 10 μM substrate). Release of free AMC was determined in a time course using a FLUOstar Optima fluorescence plate reader (BMB Lab Technologies, Offenburg, Del.). After total hydrolysis of the substrates, kcatlKm was calculated using the following formula: kcat/Km=kobsIEt, where kobs is determined as the decrease per second of the natural logarithm of substrate left, and Et is the concentration of enzyme active sites in the reaction.
Table 1 shows that both Boc-GRR-AMC and Z-FR-AMC are good substrates for Atmc9, while Boc-GKR-AMC is a somewhat less good substrate. Although H-AFK-AMC is less efficiently cleaved by Atmc9, these results directly demonstrate that Atmc9 is an arginine- and lysine-specific protease.
To further characterize Atmc9 biochemically, the purified protein and its cysteine mutant were tested for their ability to cleave the synthetic fluorogenic oligopeptide substrate t-butyloxycarbonyl-GKR-7-amido-4-methylcoumarin (Boc-GKR-AMC) at different pH. As shown in
Activation by acidic pH has also been observed for human caspase 3 (Roy et al., 2001). In this case, a so-called “safety catch” hinders both the autocatalytic maturation as well as the vulnerability to proteolytic activation by upstream proteases. However, while this activation is stable in the case of caspase 3, i.e., once mature the protease shows optimal activity at pH 7.0-8.0 (Garcia-Calvo et al., 1999), preincubation of Atmc9 at low pH is not sufficient to irreversibly activate it.
We also assessed the sensitivity of Atmc9 for several protease inhibitors, chelating agents, metal ions, and stabilizing agents in the GKR-ase assay (Table 2). Atmc9 was strongly inhibited by leupeptin and antipain at concentrations as low as 1 μM, whereas benzamidine and iodoacetamide inhibited Atmc9 activity at the millimolar range. Chymostatin and N□-tosyl-L-phenylalanyl-chloromethyl ketone (TPCK), two inhibitors of chymotrypsin proteases, were weak inhibitors of Atmc9, but the protease inhibitors aprotinin, PMSF, L-trans-epoxysuccinyl-leucylamide-(4-guanido)-butane (E-64), pepstatin, and soybean trypsin inhibitor had no significant blocking capacity. Of the irreversible oligopeptide inhibitors tested, only Z-FK-tbmk inhibited Atmc9 activity at the micromolar range. On the other hand, the caspase inhibitors and the cathepsin B inhibitor Z-FA-fluoromethyl ketone (fmk) had no effect at concentrations up to 100 μM. Of the metal ions, only zinc strongly inactivated Atmc9, and copper and nickel mildly. To optimize the assay conditions for Atmc9 activity, several stabilizing agents were tested. We found that addition of 10% (w/v) sucrose in combination with 0.1% (w/v) CHAPS almost doubled Atmc9 activity.
Percentage of the activity of recombinant Atmc9 in 50 mM MES (pH 5.3) and 10 mM DTT. Abbreviations: cmk, chloromethyl ketone; E-64, L-trans-epoxysuccinyl-leucylamide-(4-guanido)-butane; fmk, fluoromethyl ketone; TPCK, N□-tosyl-L-phenylalanyl-chloromethyl ketone; Z-FM-tbmk, Z-FK-2,4,6-trimethylbenzoyloxymethyl ketone
Because Atmc9 is only active at low pH, it was checked if it was localized in the central vacuole. Therefore, C-terminal green fluorescent protein (GFP) fusions of Atmc9, and in parallel Atmc1, Atmc2 and Atmc3, were overproduced in tobacco Bright Yellow 2 (BY-2) cells and their subcellular localization determined by confocal laser scanning microscopy (
For generation of the prodomain deletion mutant of Arabidopsis thaliana metacaspase 3 (MC3ΔN), residues 1 to 91 were replaced by a methionine residue by PCR, using 5′-ATGGCAGTTTTATGCGGCGTGAAC-3′ (SEQ ID NO:43) as the forward primer and 5′-TCAGAGTACAAACTTTGTCGCGT-3′ (SEQ ID NO:17) as the reverse primer. 5′ extensions used for Gateway™ (Invitrogen) cloning were 5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTCCACC-3′ (SEQ ID NO:44) for forward primers and 5′-GGGGACCACTTTGTACAAGAAAGCTGGGTC-3′ (SEQ ID NO:45) for reverse primers. For bacterial production, the cDNA's were cloned into the bacterial expression vector pDEST17™ (Invitrogen), resulting in the amino-terminal translational addition of the following HIS6 tag-containing sequence: MSYYHHHHHHLESTSLYKKAGST (SEQ ID NO:37).
Activity of purified metacaspase 3 was tested with different fluorescent substrates in assay buffers of pHs ranging from 4.5 to 9.0 (MES 50 mM). The substrates tested were: Ac-DEVD-AMC, Z-VAD-AMC, Boc-GRR-AMC, Boc-GKR-AMC, Z-FR-AMC and H-AFK-AMC. Only Z-FR-AMC was cut by metacaspase 3. No activity was detected using the other substrates.
A comparison was made between full length (MC3) and a prodomain deletion mutant of wild-type metacaspase 3 (MC3AN) or the C/A mutant (MC3ANC/A). Activity was significant only after addition of the kosmotrope sodium citrate (Na citr., 1 M), in absence of this agent the proteins were not active. The activity showed a clear optimum at pH 8 for the prodomain deletion mutant (Table 3).
Table 3: Activit y of full length metacaspase 3, and the prodomain deletion mutant in function of the pH, using Z-FR-AMC as substrate. “No enz” was incubated at pH8, without addition of metacaspase.
Simillion, C., Vandepoele, K., Van Montagu, M. C., Zabeau, M., and Van De Peer, Y. (2002) The hidden duplication past of Arabidopsis thaliana. Proc. Natl. Acad. Sci. USA 99, 13627-Solomon, M., Belenghi, B., Delledonne, M., Menachem, E. and Levine, A. (1999) The involvement of cysteine proteases and protease inhibitor genes in the regulation of programmed cell death in plants. Plant Cell, 11, 431-443.
| Number | Date | Country | Kind |
|---|---|---|---|
| 03075723.1 | Mar 2003 | EP | regional |
This application is a continuation of PCT International Patent Application No. PCT/EP2004/050285, filed on Mar. 10, 2004, designating the United States of America, and published, in English, as PCT International Publication No. WO 2004/081168 A2 on Sep. 23, 2004, which itself claims priority from EP 03075723.1, filed on Mar. 11, 2003, the contents of the entirety of both of which are incorporated by this reference.
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/EP04/50285 | Mar 2004 | US |
| Child | 11225709 | Sep 2005 | US |
